Please assess the completion status of the following clinical trial:

Trial Title: Dichoptic Virtual Reality Therapy for Amblyopia in Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Interpupillary distance of 60-66 mm~* Age 15-40~* Anisometropic amblyopia or strabismic amblyopia~* Best corrected visual acuity of 20/30 or worse in the amblyopic eye~* No prior therapeutic use of the software~* No other ongoing therapies including patching or recent eye muscle surgery~* No vested interest in the product~* Ability attend visits and complete the training session, and to stop the intervention after the specified intervention period~Exclusion Criteria:~* Stimulus-deprivation amblyopia.~* Organic lesions of the eye preventing the establishment of good vision (eg. media opacities, abnormalities in the fundus or optic nerve).~* Lesions of the brain preventing the establishment of good vision (eg. cortical visual impairment).~* Establishment of normal vision by refractive adaptation (wearing glasses after presentation).~* Patients diagnosed with Photosensitive Epilepsy.~* Inability to comply with the follow-up visits required.~* History of pathologic nystagmus (congenital or sensory).

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Patching therapy (Type: ACTIVE_COMPARATOR): Patching treatment followed by crossover to dichoptic virtual reality video game treatment arm using Diplopia (TM) software developed for the Oculus Rift (R) game system.
- Dioptic (non-dichoptic) therapy (Type: ACTIVE_COMPARATOR): Dioptic (non-dichoptic) therapy followed by crossover to dichoptic virtual reality video game treatment arm using Diplopia (TM) software developed for the Oculus Rift (R) game system.
- Dichoptic therapy (Type: EXPERIMENTAL): Dichoptic virtual reality video game treatment using Diplopia (TM) software developed for the Oculus Rift (R) game system.

Based on this trial design, predict the completion outcome and termination type (if applicable).